Billionaire Stanley Druckenmiller Sold Nvidia and Palantir and Piled Into One of Wall Street’s Hottest Drug Stocks Ahead of 2026

view original post

Duquesne Family Office’s billionaire boss has jettisoned the faces of the artificial intelligence (AI) revolution in favor of a drugmaker whose shares have rallied 191% since the beginning of 2024.